CAGRILINTIDE PEPTIDE 5MG/10MG VIAL

Cagrilintide is a highly advanced, long-acting synthetic analogue of the naturally occurring pancreatic hormone amylin. Its primary mechanism of action involves acting as a powerful, non-selective agonist at both amylin and calcitonin receptors within the brain. By aggressively agonizing these neural pathways, Cagrilintide drastically delays gastric emptying, forcefully inhibits the secretion of postprandial glucagon, and deeply suppresses the neurological drive for caloric intake, resulting in profound systemic satiety. In elite-level metabolic and obesity research, it is exceptionally prized for its unparalleled ability to drive massive reductions in total body weight and visceral adiposity. It is frequently utilized in synergistic protocols alongside GLP-1 receptor agonists to completely overwrite natural appetite cues and rapidly reverse severe metabolic dysfunction.